the aid library

LIST OPTIONS

Filter

5175

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (267)

View PDF (135)

WHO Emergency Response Framework - Internal WHO procedures - Second Edition

World Health Organization WHO (2024) C_WHO

The ERF provides WHO staff with essential guidance on how the Organization manages the assessment, grading and response to public health events and emergencies with health consequences, in support of Member States and affected communities. The ERF adopts an all-hazards approach and it is therefore a... more

Download (1764)

View PDF (2851)

Antenatal Guidelines for Primary Health Care in Crisis Conditions

Cristina Otero Garcia ICRC (2005)

These guidelines are designed for ICRC and other health professionals – nurses, midwifes, doctors – who either lack experience in antenatal care or are not used to working in countries where medical infrastructure is underdeveloped or non-existent

Download (271)

View PDF (565)

Advocacy, communication & social mobilization (ACSM) for tuberculosis control (Handbook)

World Health Organization, Stop TB Partnership (2007) C_WHO

A Handbook for country programmes

Download (688)

View PDF (1340)

Ghana National Health Policy: Creating Wealth through Health

Ministry of Health Ghana; (2007) C1

External Link

Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta- Analysis of Randomized Trials

H. T. Ayele, M. S. M. van Mourik, T. P. A. Debray, et al. PLOS One (2015) CC

PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16

Download (716)

View PDF (910)

A strategic approach to reproductive, maternal, newborn,child and adolescent health (RMNCH+A ) in India

Ministry of Health and Social Welfare, Government of India (2013) C1

Download (370)

View PDF (509)

National Strategic Plan for Tuberculosis 2016-2020

The Republic of the Union of Myanmar, Ministry of Health and Sports (2016) C1

National Tuberculosis Programme
The National Strategic Plan (NSP) for Tuberculosis (TB) 2016-2020 builds on the past experiences for the National Tuberculosis Programme and its partners. This NSP provides a roadmap for delivering quality TB prevention and care service to the entire population, ... more

External Link

Humanitarian Health Ethics Analysis Tool: HEAT Handbook

Fraser V, Hunt MR, Schwartz L, and de Laat S (2014)

You can download the handbook, worksheets and quick reference cards from the website! The HHEAT is an ethical analysis tool designed to help humanitarian healthcare workers make ethical decisions. It consists of 3 components: (1) a summary card highlighting key questions, (2) a handbook providing a... more

Download (971)

View PDF (2347)

Fractional dose yellow fever vaccine as a dose-sparing option for outbreak response

World Health Organization WHO (2016) C_WHO

WHO Secretariat Information paper July 2016

Download (868)

View PDF (1374)

Guidelines for Prevention and Management of Common Opportunistic Infections/Malignancies among HIV-Infected Adult and Adolescent

National AIDS Control Organisation, Ministry of Health & Family Welfare , Government of India, (2007) C1

Download (784)

View PDF (638)

Service Standards and Service Delivery Standards for the Health Sector

Republic of Uganda, Ministry of Health (2016) C1

The Ministry of Health has developed the first version of the Service Standards and Service Delivery Standards for the health sector in Uganda. The main objective is to provide a common understanding of what is expected by the public, service users and service providers in ensuring provision of cons... more

Download (158)

View PDF (216)

Adolescent HIV Care and Treatment: A Training Curriculum for Health Workers - Trainer Manual (Introduction Section 1-3)

T. Colton; V. Allread; E. Abrams; et al. ICAP Columbia University (Mailman School of Public Health) (2012) C2

Trainer Manual Introduction (Section 1-3)